Conference Reports

Macau
14 December 2019 - 14 December 2019
Philadelphia, Pennsylvania, US
16 November 2019 - 18 November 2019
Singapore
08 November 2019 - 10 November 2019
Barcelona, Spain
16 September 2019 - 20 September 2019
San Francisco, California, US
25 September 2019 - 29 September 2019
Pasay City
22 May 2019 - 26 May 2019
Lisbon, Portugal
17 March 2019 - 19 March 2019
New Orleans, Louisiana
16 March 2019 - 18 March 2019
Honolulu, Hawaii, US
06 February 2019 - 08 February 2019
Kuala Lumpur
18 January 2019 - 20 January 2019
Kuala Lumpur
22 November 2018 - 25 November 2018
Chicago, Illinois, US
10 November 2018 - 12 November 2018
San Diego, California, US
21 September 2018 - 25 September 2018
Bangkok, Thailand
28 September 2018 - 01 October 2018
Munich
25 August 2018 - 29 August 2018
Barcelona
18 March 2018 - 20 March 2018
Orlando, Florida
10 March 2018 - 12 March 2018
Los Angeles, California, US
24 January 2018 - 26 January 2018
Abu Dhabi
04 December 2017 - 08 December 2017
Anaheim, California, US
11 November 2017 - 15 November 2017
Singapore
20 October 2017 - 21 October 2017
Singapore
06 October 2017 - 08 October 2017
Barcelona
26 August 2017 - 30 August 2017
Singapore
13 July 2017 - 15 July 2017
San Diego, California, US
09 June 2017 - 13 June 2017
Houston, Texas, US
22 February 2017 - 24 February 2017
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 27 Jun 2019
Accelerated cognitive decline is significantly associated with incident coronary heart disease (CHD) after, but not before or immediately following, ischaemic events, suggests a recent study.
12 Jan 2020
Levels of high-sensitivity C-reactive protein (hs-CRP) in the serum are predictive of more severe coronary artery disease (CAD), reports a recent study.
17 Jan 2020
Bicuspid and tricuspid aortic valve patients have comparable 30-day and 1-year mortality outcomes after transcatheter aortic valve replacement (TAVR), reports a recent meta-analysis. Rates of stroke and new pacemaker implants are likewise similar.
Christina Lau, 02 Jan 2020

Tolvaptan improves dyspnoea, increases sodium levels and reduces body weight in patients with acute heart failure (HF) with or without hyponatraemia, but no significant effect is seen in mortality or rehospitalization, according to a recent meta-analysis.